Press Release: California Assembly Passes Bill to Address Inflated Medical Claims by Dialysis, Drug Treatment Industries

The California Assembly passed a bill Sept. 10 to address runaway costs and rein in a profiteering scheme involving the dialysis and addiction treatment industries, and it now heads to Gov. Gavin Newsom, who has until Oct. 13 to decide whether to sign it into law.

CAHP Statement: Individual Health Coverage Premiums for 2020 Reflect California’s Bold Steps to Increase Affordability

Covered California today announced preliminary health insurance rates for 2020, citing an average weighted statewide rate change of .8 percent, the lowest premium increase since the exchange was established in 2014.

Press Release: Senate Health Committee Passes Bill to Address Runaway Costs in Dialysis, Drug Treatment Industries

The Senate Health Committee passed legislation today to address runaway costs and rein in a profiteering scheme by third party health providers – including in the dialysis and addiction treatment industries.

Press Release: CA Assembly Passes Bill to Rein in Outsized Costs in Dialysis, Drug Treatment Industries

The California State Assembly today passed legislation by a bipartisan vote to contain costs in the dialysis and drug treatment industries that currently result in higher health care costs for all consumers.

CAHP Statement: Response To Governor’s May Budget Revise Release

California Association of Health Plans (CAHP) President & CEO Charles Bacchi today issued the following statement in response to Gov. Gavin Newsom’s release of the May budget revise.

CAHP Statement: CAHP Releases Research Review On Northwestern University Finding that Medicaid Managed Care Lowers Drug Costs

The California Association of Health Plans today has released a research review of a recent non-partisan nationwide study conducted by a team of Northwestern University professors which found that allowing managed care organizations (MCO’s) to administer the majority of Medicaid drug benefits, as we currently do in California, significantly reduces state spending on prescription drugs.

CAHP Statement: CAHP Hires New Director of Regulatory Affairs and State Programs Analyst

The California Association of Health Plans (CAHP) today announced that Christina Wu is the association’s new Director of Regulatory Affairs and Ellesse Flores has joined the staff as State Programs Analyst.

CAHP Statement: Bill Designed to Lower Prescription Drug Prices by Cracking Down on Pharma’s Pay-for-Delay Schemes Passes Assembly Health Committee

AB 824, a bill that would curb increasing drug prices in Californiaby allowing more generic drugs to enter thehealth caremarketplace, cleared the Assembly Health Committee this afternoon. The measure, introduced by Assembly Health Committee Chairman Jim Wood (D-Santa Rosa)inpartnership with Attorney General Xavier Becerra, would prohibit “pay-for-delay” agreements where a pharmaceutical company transfers anything of value to delay a competitor’s research, marketing, or sale of a competing version of its drug.

CAHP Statement: Assembly Health Committee Passes Bill to Stop Third Party Payer Scheme from Driving Up Health Care Costs for All

Legislation designed toincreaseconsumer protection by reining-in a profiteering scheme operated by the dialysis and drug rehabilitation industries passed the Assembly Health Committee on a bipartisan vote.

CAHP Statement: New RunawayRx Infographics Explain California’s Drug Price Transparency Law and How It’s Working to Reveal How Rx Costs Impact Health Plan Premiums

RunawayRx today released two new infographics. One highlightskey implementation dates for California’s landmark prescription drug transparency law, SB 17, and the other revealsnew details about how prescription drug costs are impacting California health plan premiums.

© California Association of Health Plans

Privacy Policy | Disclaimer